DUPONT CAPITAL MANAGEMENT CORP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$690,000
+99.4%
13,744
+59.4%
0.04%
+156.2%
Q2 2022$346,000
+7.5%
8,6250.0%0.02%
+23.1%
Q1 2022$322,000
-13.9%
8,625
-8.1%
0.01%0.0%
Q4 2021$374,000
-23.5%
9,388
-28.5%
0.01%
-13.3%
Q3 2021$489,000
-22.9%
13,131
-12.4%
0.02%0.0%
Q2 2021$634,000
-10.7%
14,9890.0%0.02%
-11.8%
Q1 2021$710,000
-35.6%
14,989
-17.0%
0.02%
-26.1%
Q4 2020$1,102,000
+21.5%
18,063
-6.9%
0.02%
+15.0%
Q3 2020$907,000
-13.7%
19,411
-6.3%
0.02%
-13.0%
Q2 2020$1,051,000
-12.7%
20,712
-23.3%
0.02%
-20.7%
Q1 2020$1,204,000
-5.0%
26,995
+2.4%
0.03%
+3.6%
Q4 2019$1,267,000
+111.5%
26,375
+48.9%
0.03%
+100.0%
Q3 2019$599,000
-32.2%
17,717
-9.7%
0.01%
-30.0%
Q2 2019$883,000
+99.8%
19,617
+67.1%
0.02%
+100.0%
Q1 2019$442,000
+9.7%
11,7410.0%0.01%0.0%
Q4 2018$403,00011,7410.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders